Your facility is not maintained in a good state of repair, creating insanitary conditions whereby drug products may be contaminated with filth.
Inspection Record
Pharmaneek Inc — FDA 483 Findings
Inspectors Janet A. RajanThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Your firm failed to confirm that the quality of water was suitable for its intended use in the production of non-sterile drug products.
Hazardous drugs were produced without providing adequate containment segregation, and/or cleaning of work surfaces, utensils, and/or personnel to prevent cross-contamination.
About this record
Extracted automatically from the document US FDA published on 2026-06-22. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
